B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia, lymphoma and rheumatoid arthritis. 3D rendering based on protein data bank entry 2osl. Stick representation combined with semi-transparent surfaces. Dark background
View Full Image on Dreamstime
Keywords:
pdb2oslcd20cd20clusterdifferentiationblymphocytelymphocytebcellantigenms4a1surfacelymphomaleukemiaimmunohistochemistryhistologyantibodyrituximabfabepitopeautoimmunecancerrheumatoidarthritispurpurathrombocytopenicpemphigusvulgarismonoclonalstructurepeptideproteinaminoacidmoleculepolypeptidepolymeratomssciencescientificdiseasehealthmolecularmodel3drenderingillustrationdarkbackgroundblacktransparentartisticstylized
Username: Molekuul
Editorial: No
Width: 5000 pixels
Height: 3940 pixels
Downloads: 2
Image ID: 188464569